Shangxian Minimal Invasive

Shangxian Minimal Invasive Inc (short for SMI Inc) was established in 2010 dedicated to providing quality products for GI tract disease diagnosis and treatment with registered funds of US$3.5 million. A series of products with patents has been developed and strict quality control system has been adopted. Products from the company meet ISO 13485 and CFDA requirements and recognized by CE system. Within 13 years, over 320 distributors from 56 countries choose to join us, serving over 70 countries and regions around the world. Main marketing include: Germany, France, Italy, Australia, Japan, Korea etc., a quarter of them are respected names in local medical domain. SMI will keep providing great service to customers, we hope to explore markets worldwide with our partners, meet the needs of market with diversification, quality and superior service.